INNOVATION IN HIGHER EDUCATION. AN EXPERIENCE OF INTERNATIONAL COLLABORATION

The academic community, in general, is understood to encompass an environment for knowledge acquisition, supportive of research into new realms, and the encouragement of learning. The “oratory” means of conveying knowledge with one person speaking and others listening — created the basis for the “lecturing” approach to transmitting knowledge. In the twentieth century, “field trips” were an opportunity for “getting out” of the formal classroom and for learning in other environments. The industrial and education fields have long believed in and utilized the “apprenticeship” system and approach to learning. Laboratory experiences have dominated the biology, chemistry, and physics classrooms and more recently many of these experiences have been extended to field activities, outside of the formal classroom/school environment

Advancing Vaccine Equity through Community-Based Organizations: Partnering for Vaccine Equity Program Annual Evaluation ReportYear One

The Centers for Disease Control and Prevention (CDC) launched the Partnering for Vaccine Equity (P4VE) program in 2020 to address racial and ethnic disparities in adult immunization rates, particularly for COVID-19 and influenza. In 2021, P4VE directed $156 million to over 500 national, state, and community-based organizations (CBOs) to improve equitable access to vaccination in communities by promoting vaccine confidence and addressing barriers to vaccination opportunities.The Urban Institute is partnering with CDC to support a subset of CBOs participating in the P4VE program. In the first year of the P4VE initiative (April 30, 2021, to April 29, 2022), the Urban Institute provided grant subawards and tailored program support and technical assistance to 29 CBOs. This report presents findings from an evaluation of CBOs' performance on P4VE program objectives in the first year, including challenges and successes CBOs experienced in their efforts to improve vaccine equity

Clinical evaluation, imaging studies, indications for cytologic study, and preprocedural requirements for duct brushing studies and pancreatic FNA: The papanicolaou society of cytopathology recommendations for pancreatic and biliary cytology

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/106723/1/dc23095.pd

Differentiation of pancreatic cysts with optical coherence tomography (OCT) imaging: an ex vivo pilot study

We demonstrate for the first time that optical coherence tomography (OCT) imaging can reliably distinguish between morphologic features of low risk pancreatic cysts (i.e., pseudocysts and serous cystadenomas) and high risk pancreatic cysts (i.e., mucinous cystic neoplasms and intraductal papillary mucinous neoplasms). In our study fresh pancreatectomy specimens (66) from patients with cystic lesions undergoing surgery were acquired and examined with OCT. A training set of 20 pathology-OCT correlated tissue specimens were used to develop criteria for differentiating between low and high risk cystic lesions. A separate (validation) set of 46 specimens were used to test the OCT criteria by three clinicians, blinded to histopathology findings. Histology was finally used as a ‘gold’ standard for testing OCT findings. OCT was able to reveal specific morphologic features of pancreatic cysts and thus to differentiate between low-risk and high-risk cysts with over 95% sensitivity and specificity. This pilot study suggests that OCT could be used by clinicians in the future to more reliably differentiate between benign and potentially malignant pancreatic cysts. However, in vivo use of OCT requires a probe that has to fit the bore of the pancreas biopsy needle. Therefore, we have developed such probes and planned to start an in vivo pilot study within the very near future